<https://rdf.molmedb.upol.cz/reference/ref4254> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495361>;
	<http://purl.org/dc/terms/bibliographicCitation> "Ribeiro CJA, Kankanala J, Xie J, Williams J, Aihara H, Wang Z.: Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors. Bioorg Med Chem Lett, Volume 29 (2), 2019"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "30522956"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494987>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2018.11.044"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>,
		<https://identifiers.org/molmedb/MM494977> .
<https://rdf.molmedb.upol.cz/interaction/int1021833> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4254> .
<https://rdf.molmedb.upol.cz/interaction/int1021229> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4254> .
<https://rdf.molmedb.upol.cz/interaction/int1021244> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4254> .